Fields »
ABOUT
HELP
BLOG

354 GENES FOUND

Show / hide columns

XML | RDF | TSV | Page of 8 | next »

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Cell

Pathology

 

 

 

 

 

 

Subcellular location

x

Prognostic p-value

x

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
FAM83AFamily with sequence similarity 83, member APredicted intracellular proteins
NucleoplasmLung cancer: 2.98e-9
Pancreatic cancer: 4.99e-6
Endometrial cancer: 3.85e-4
Tissue enriched
GALNT2Polypeptide N-acetylgalactosaminyltransferase 2Enzymes
Plasma proteins
Predicted secreted proteins
Golgi apparatusRenal cancer: 2.79e-13
Lung cancer: 8.48e-8
Cervical cancer: 1.22e-6
Expressed in all
LOXL2Lysyl oxidase-like 2Enzymes
Predicted intracellular proteins
Predicted secreted proteins
NucleoplasmLung cancer: 1.46e-7
Renal cancer: 2.91e-7
Cervical cancer: 9.83e-6
Glioma: 1.78e-4
Pancreatic cancer: 9.05e-4
Tissue enhanced
FSTL3Follistatin-like 3 (secreted glycoprotein)Cancer-related genes
Disease related genes
Predicted intracellular proteins
Predicted secreted proteins
NucleoplasmLung cancer: 4.61e-7
Ovarian cancer: 1.65e-4
Colorectal cancer: 3.01e-4
Endometrial cancer: 3.03e-4
Expressed in all
BCAR3Breast cancer anti-estrogen resistance 3Predicted intracellular proteins
Plasma membrane
Centrosome
Cytosol		Renal cancer: 3.08e-7
Lung cancer: 8.92e-7
Pancreatic cancer: 4.38e-4
Liver cancer: 5.42e-4
Head and neck cancer: 8.41e-4
Mixed
CMIPC-Maf inducing proteinPredicted intracellular proteins
Nucleoplasm
Cytosol		Lung cancer: 9.47e-7
Thyroid cancer: 1.05e-4
Expressed in all
IER5LImmediate early response 5-likePredicted intracellular proteins
NucleusLung cancer: 1.48e-6
Mixed
MYO1EMyosin IEDisease related genes
Predicted intracellular proteins
Lung cancer: 1.57e-6
Endometrial cancer: 4.19e-4
Pancreatic cancer: 7.99e-4
Expressed in all
SP6Sp6 transcription factorPredicted intracellular proteins
Transcription factors
Nucleoplasm
Mitotic spindle
Centrosome		Lung cancer: 2.11e-6
Urothelial cancer: 5.72e-4
Stomach cancer: 6.39e-4
Tissue enhanced
COL22A1Collagen, type XXII, alpha 1Predicted intracellular proteins
Predicted secreted proteins
Endoplasmic reticulum
Vesicles		Lung cancer: 2.13e-6
Glioma: 3.62e-4
Tissue enhanced
LDHALactate dehydrogenase ACancer-related genes
Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Vesicles
Cytosol		Renal cancer: 9.69e-9
Liver cancer: 3.26e-8
Lung cancer: 2.27e-6
Pancreatic cancer: 8.09e-6
Cervical cancer: 2.78e-5
Expressed in all
L1CAML1 cell adhesion moleculeCD markers
Disease related genes
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Nucleoplasm
Plasma membrane		Endometrial cancer: 8.51e-10
Lung cancer: 2.36e-6
Renal cancer: 1.17e-4
Head and neck cancer: 3.81e-4
Tissue enhanced
PLCD3Phospholipase C, delta 3Enzymes
Plasma proteins
Predicted intracellular proteins
Plasma membraneLung cancer: 2.89e-6
Thyroid cancer: 4.28e-4
Mixed
ITGB1Integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)Cancer-related genes
CD markers
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Transporters
Endoplasmic reticulum
Plasma membrane
Focal adhesion sites		Lung cancer: 3.36e-6
Cervical cancer: 5.01e-4
Expressed in all
LAMC2Laminin, gamma 2Disease related genes
Plasma proteins
Predicted secreted proteins
CytosolLung cancer: 4.20e-6
Pancreatic cancer: 7.11e-5
Mixed
SERPINE1Serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1Cancer-related genes
Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
CytosolRenal cancer: 5.88e-8
Stomach cancer: 3.27e-6
Lung cancer: 4.41e-6
Head and neck cancer: 2.84e-5
Colorectal cancer: 2.82e-4
Cervical cancer: 5.01e-4
Urothelial cancer: 5.51e-4
Tissue enhanced
STK24Serine/threonine kinase 24Enzymes
Predicted intracellular proteins
Nucleoli
Cytosol		Lung cancer: 6.23e-6
Renal cancer: 6.91e-5
Pancreatic cancer: 5.81e-4
Expressed in all
GPRIN1G protein regulated inducer of neurite outgrowth 1Predicted intracellular proteins
Vesicles
Plasma membrane		Renal cancer: 2.79e-7
Lung cancer: 6.83e-6
Tissue enriched
RCN1Reticulocalbin 1, EF-hand calcium binding domainPredicted intracellular proteins
Predicted secreted proteins
Endoplasmic reticulumRenal cancer: 2.70e-13
Lung cancer: 7.13e-6
Expressed in all
PLIN3Perilipin 3FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Lipid droplets
Cytosol		Renal cancer: 9.15e-7
Lung cancer: 7.67e-6
Liver cancer: 3.27e-5
Endometrial cancer: 2.62e-4
Expressed in all
DKK1Dickkopf WNT signaling pathway inhibitor 1Predicted secreted proteins
Head and neck cancer: 4.35e-8
Lung cancer: 7.80e-6
Pancreatic cancer: 1.27e-4
Tissue enhanced
DUSP5Dual specificity phosphatase 5Enzymes
Predicted intracellular proteins
Lung cancer: 8.30e-6
Mixed
PTX3Pentraxin 3, longPlasma proteins
Predicted secreted proteins
Endometrial cancer: 8.35e-9
Lung cancer: 8.75e-6
Head and neck cancer: 6.36e-4
Tissue enhanced
LDLRAD3Low density lipoprotein receptor class A domain containing 3Predicted membrane proteins
Cell JunctionsRenal cancer: 5.05e-8
Lung cancer: 9.34e-6
Urothelial cancer: 2.14e-5
Cervical cancer: 2.24e-4
Mixed
C1QTNF6C1q and tumor necrosis factor related protein 6Predicted intracellular proteins
NucleusRenal cancer: 0.00e+0
Lung cancer: 9.60e-6
Tissue enhanced
TLDC1TBC/LysM-associated domain containing 1Plasma proteins
Predicted intracellular proteins
Nucleus
Nucleoli
Cytosol		Lung cancer: 1.03e-5
Pancreatic cancer: 7.05e-5
Mixed
AREGAmphiregulinCancer-related genes
Predicted membrane proteins
MitochondriaLung cancer: 1.05e-5
Head and neck cancer: 2.61e-5
Pancreatic cancer: 8.32e-5
Tissue enhanced
SPECC1Sperm antigen with calponin homology and coiled-coil domains 1Cancer-related genes
Disease related genes
Predicted intracellular proteins
Lung cancer: 1.06e-5
Expressed in all
ERO1AEndoplasmic reticulum oxidoreductase alphaPlasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Renal cancer: 6.54e-9
Lung cancer: 1.10e-5
Pancreatic cancer: 2.27e-4
Liver cancer: 7.59e-4
Cervical cancer: 8.47e-4
Expressed in all
EXT1Exostosin glycosyltransferase 1Cancer-related genes
Disease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Lung cancer: 1.20e-5
Thyroid cancer: 4.64e-4
Cervical cancer: 7.04e-4
Expressed in all
KRT6CKeratin 6C, type IIDisease related genes
Plasma proteins
Predicted intracellular proteins
Intermediate filamentsLung cancer: 1.23e-5
Tissue enriched
MDFIMyoD family inhibitorPredicted intracellular proteins
NucleoplasmRenal cancer: 2.85e-6
Lung cancer: 1.32e-5
Melanoma: 9.11e-4
Tissue enhanced
CDCP1CUB domain containing protein 1CD markers
Predicted membrane proteins
Predicted secreted proteins
Lung cancer: 1.41e-5
Pancreatic cancer: 1.48e-4
Mixed
EREGEpiregulinPredicted membrane proteins
VesiclesCervical cancer: 1.67e-7
Lung cancer: 1.45e-5
Pancreatic cancer: 6.57e-5
Tissue enriched
MESDC1Mesoderm development candidate 1Predicted intracellular proteins
VesiclesRenal cancer: 1.87e-7
Lung cancer: 1.47e-5
Mixed
SNAI1Snail family zinc finger 1Predicted intracellular proteins
Transcription factors
Nucleus
Cytosol		Renal cancer: 2.63e-7
Thyroid cancer: 8.82e-7
Lung cancer: 1.61e-5
Colorectal cancer: 4.76e-4
Tissue enhanced
SLC16A3Solute carrier family 16 (monocarboxylate transporter), member 3Predicted membrane proteins
Transporters
Nuclear membrane
Plasma membrane		Liver cancer: 1.19e-7
Renal cancer: 3.71e-7
Lung cancer: 2.02e-5
Cervical cancer: 6.07e-4
Expressed in all
FLNCFilamin C, gammaDisease related genes
Plasma proteins
Predicted intracellular proteins
Plasma membrane
Cytosol		Lung cancer: 2.17e-5
Urothelial cancer: 3.73e-5
Glioma: 2.14e-4
Renal cancer: 5.69e-4
Tissue enhanced
FADDFas (TNFRSF6)-associated via death domainCancer-related genes
Disease related genes
Predicted intracellular proteins
Nucleoplasm
Cytosol		Lung cancer: 2.21e-5
Head and neck cancer: 8.22e-5
Thyroid cancer: 3.45e-4
Cervical cancer: 6.35e-4
Expressed in all
PLK1Polo-like kinase 1Cancer-related genes
Disease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
Renal cancer: 0.00e+0
Liver cancer: 2.70e-7
Lung cancer: 2.28e-5
Pancreatic cancer: 4.12e-4
Tissue enhanced
PLAURPlasminogen activator, urokinase receptorCancer-related genes
CD markers
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Plasma membraneRenal cancer: 7.83e-9
Lung cancer: 2.33e-5
Expressed in all
PIEZO1Piezo-type mechanosensitive ion channel component 1Disease related genes
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Renal cancer: 8.89e-7
Lung cancer: 2.36e-5
Cervical cancer: 2.37e-4
Ovarian cancer: 3.78e-4
Mixed
KLF10Kruppel-like factor 10Predicted intracellular proteins
Transcription factors
Lung cancer: 2.61e-5
Expressed in all
ARL14ADP-ribosylation factor-like 14Predicted intracellular proteins
Lung cancer: 2.64e-5
Pancreatic cancer: 6.71e-4
Tissue enhanced
S100A10S100 calcium binding protein A10Predicted membrane proteins
MitochondriaRenal cancer: 3.80e-8
Lung cancer: 2.66e-5
Liver cancer: 1.00e-4
Head and neck cancer: 3.33e-4
Urothelial cancer: 3.84e-4
Pancreatic cancer: 3.88e-4
Expressed in all
AHNAK2AHNAK nucleoprotein 2Cancer-related genes
Predicted intracellular proteins
Plasma membrane
Cytosol		Pancreatic cancer: 4.05e-6
Urothelial cancer: 2.23e-5
Lung cancer: 2.79e-5
Tissue enriched
VDAC1Voltage-dependent anion channel 1Plasma proteins
Predicted intracellular proteins
CytosolLung cancer: 2.87e-5
Head and neck cancer: 4.90e-4
Breast cancer: 5.30e-4
Liver cancer: 8.49e-4
Expressed in all
PKP3Plakophilin 3Plasma proteins
Predicted intracellular proteins
Nucleoplasm
Cell Junctions
Cytosol		Lung cancer: 2.89e-5
Renal cancer: 1.08e-4
Pancreatic cancer: 3.93e-4
Tissue enhanced
TK1Thymidine kinase 1, solubleCancer-related genes
Enzymes
Plasma proteins
Predicted intracellular proteins
Renal cancer: 6.50e-11
Lung cancer: 3.03e-5
Liver cancer: 6.87e-4
Mixed
S100A16S100 calcium binding protein A16Predicted intracellular proteins
Plasma membrane
Cytosol		Lung cancer: 3.14e-5
Renal cancer: 3.91e-5
Pancreatic cancer: 2.04e-4
Liver cancer: 3.18e-4
Tissue enhanced

Page of 8 | next »

Contact

The Project

The Human Protein Atlas

The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg foundation.